MedTrace Logo

BVAIT: B-Vitamin Atherosclerosis Intervention Trial

NCT00114400 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 506

Last updated 2009-12-11

No results posted yet for this study

Summary

The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).

Conditions

Interventions

DRUG

folic acid

DRUG

vitamin B12

DRUG

vitamin B6

Sponsors & Collaborators

  • Leiner Health Products

    collaborator INDUSTRY

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Howard N. Hodis, MD · University of Southern California, Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-11-30
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00114400 on ClinicalTrials.gov